Courtney Barnes

"Over 131 million people in the United States, that’s over 66% of the population, are currently prescribed to a prescription medication," said Courtney Barnes, a partner at a New York-based cannabis and psychedelics law firm Feldman Legal Advisors. "Of those prescription medications available...

Courtney Barnes, a partner at Feldman Legal Advisors, advocate for psychedelic policy reform and upcoming guest at the Benzinga Cannabis Capital Conference positioned herself at the front lines of the legal landscape for cannabis and psychedelics, steering the conversation around regulation and...

Recent advancements within the field of mental health with the use of psilocybin-assisted therapy, as well as Colorado’s forward-thinking legislation about this therapy, have proven exciting. Psilocybin-assisted therapy showcased promising results in treating Generalized Anxiety Disorder (GAD...

In the current psychedelics landscape, one of the most important topics is compound legality.  While it's possible that MDMA-assisted therapy will eventually be federally approved in the U.S., what should investors consider when looking at a prospective business? The 2023 edition of...

The upcoming Psychedelics Capital Conference constitutes Benzinga’s effort to provide an exclusive opportunity to meet, connect with and learn from some of the most knowledgeable people in the space.  From companies that perform advanced clinical...